Gabriel Morris - Jun 11, 2024 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role: CFO, Director
Signature: /s/ Gabriel Morris
Stock symbol: IMMX
Transactions as of: Jun 11, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/21/2024, 05:45 PM
Previous filing: Jun 10, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	IMMX	Common Stock						286K	Jun 11, 2024	Direct
holding	IMMX	Common Stock						271K	Jun 11, 2024	See footnote	F1
holding	IMMX	Common Stock						24.1K	Jun 11, 2024	See footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMMX	Stock Option (Right to Buy)	Award	$0	+340K		$0.00	340K	Jun 11, 2024	Common Stock	340K	$2.04	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein.
F2	Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC ("Alwaysraise Ventures"), the general partner of Alwaysraise Ventures I, LP. ("AVILP") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein.
F3	The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.